http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100835607-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 |
| filingDate | 2006-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100835607-B1 |
| titleOfInvention | Pharmaceutical composition for alleviation and treatment of seawater diseases containing gamma-polyglutamic acid as an active ingredient |
| abstract | The present invention relates to a pharmaceutical composition for treating seawater diseases containing gamma-polyglutamic acid as an active ingredient, and more particularly, to gamma-polyglutamic acid and to lycopene. (lycopene) and / or cyclooxygenase-2 (COX-2) inhibitors and for the treatment of seawater diseases in which one or more selected from collagen, beta-glucan, isoflavones, aloe powders and psoriasis are added It relates to a pharmaceutical composition. The pharmaceutical composition of the present invention can be widely used as a medicament for rapid treatment while effectively preventing, alleviating and inhibiting seawater.n n n Gamma-polyglutamic acid, lycopene, cyclooxygenase-2 inhibitors, seawater treatment |
| priorityDate | 2006-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.